Page: Fees payable to the European Medicines Agency: General questions and answers-2025/7/10

Document: CHMP PROM minutes for the meeting on 14 April 2025-2025/8/19

Page: PRAC recommendations on safety signals-2025/9/29

Document: On-boarding of users to Substance, Product, Organisation and Referentials (SPOR) data services-2025/11/5

Document: Consultation on an ancillary medicinal substance incorporated in a medical device - Gynemed GmbH & Co. KG HSA-containing ART media-2025/12/4

Document: Guiding principles of good AI practice in drug development-2026/1/14

Document: Concept paper for the revision of the guideline on veterinary good pharmacovigilance practices (VGVP) Module: Signal Management (EMA/522332/2021)-2026/2/13

Document: Recommendations of the Executive Steering Group on the Shortages and Safety of Medicinal Products on shortages of intravenous ifosfamide and cyclophosphamide-2026/3/24

国家药监局药审中心关于发布《药审中心外聘专家增补名单（2025年第三批）》的通告（2026年第31号）-2026/4/29

Page: Class III implantable devices and Class IIb medical devices intended to administer or remove medicinal products: expert panel opinions-2026/6/10